Improved proteomic multiplex assays
A technology for testing samples, diluents, applied in the field of proteomics assays, which can solve the problems of limitations, false detection signals, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0222] Preparation of oligonucleotides
[0223] The automated synthesis of oligodeoxynucleosides is a routine practice in many laboratories (see for example Matteucci, M.D. and Caruthers, M.H., (1990) J.Am.Chem.Soc., 103 :3185-3191, the contents of which are hereby incorporated by reference in their entirety). The synthesis of oligoribonucleosides is also well known (see for example Scaringe, S.A., et al., (1990) Nucleic Acids Res. 18 :5433-5441, the contents of which are hereby incorporated by reference in their entirety). As described herein, phosphoramidites can be used to incorporate modified nucleosides into oligonucleotides by chemical synthesis, and triphosphates can be used to incorporate modified nucleosides into oligonucleotides by enzymatic synthesis. (See eg, Vaught, J.D. et al. (2004) J.Am.Chem.Soc., 126 : 11231-11237; Vaught, J.V., et al. (2010) J.Am.Chem.Soc. 132 , 4141-4151; Gait, M.J. "Oligonucleotide Synthesis a practical approach" (1984) IRL Press (Oxfor...
Embodiment approach
[0236] In some embodiments, a method is disclosed comprising: a) contacting a first test sample with a first set of aptamers to form a first mixture, wherein the first test sample is Z% of a biological sample Dilution, where Z is 5% to 39% (or 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16% of the biological sample %, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, or 39%) dilutions, and at least A is present in the first set of aptamers 3 different aptamers; b) contacting a second test sample with a second set of aptamers to form a second mixture, wherein said second test sample is a Y% dilution of said biological sample, wherein Y is less than Z, and wherein at least A is present in the second set of aptamers 2 c) contacting a third test sample with a third set of aptamers to form a third mixture, wherein said third test sample is an X% dilution of said biological sample, where X is less than Y, and In sa...
Embodiment 1
[0378] Example 1. Multiple aptamer analysis of samples
[0379] This example describes a multiplex aptamer assay for the analysis of samples and controls.
[0380] Multiplex aptamer assay method
[0381] All steps of the multiplex aptamer assay were performed at room temperature unless otherwise indicated.
[0382] Preparation of aptamer master mix solution.
[0383] The 5272 aptamers were grouped into three unique mixtures, Dil1, Dil2, and Dil3, and corresponded to 20%, 0.5%, and 0.005% plasma or serum sample dilutions, respectively. Assignment of the aptamers to the mixture was determined empirically by assaying a dilution series of matched plasma and serum samples with each aptamer and identifying the sample dilutions that gave the most linear signal range. Isolation of the aptamer and mixing with different dilutions (20%, 0.5% or 0.005%) of plasma or serum samples allowed the assay to span 10 7 fold range of protein concentration. A stock solution of the aptamer maste...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



